Annual Operating Profit
-$25.07 M
-$10.19 M-68.49%
31 December 2023
Summary:
Context Therapeutics annual operaing income is currently -$25.07 million, with the most recent change of -$10.19 million (-68.49%) on 31 December 2023. During the last 3 years, it has fallen by -$22.50 million (-874.75%). CNTX annual operating profit is now -874.75% below its all-time high of -$2.57 million, reached on 31 December 2020.CNTX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$18.70 M
-$15.61 M-505.52%
01 September 2024
Summary:
Context Therapeutics quarterly operating income is currently -$18.70 million, with the most recent change of -$15.61 million (-505.52%) on 01 September 2024. Over the past year, it has dropped by -$12.52 million (-202.59%). CNTX quarterly operating profit is now -3640.28% below its all-time high of -$500.00 thousand, reached on 31 March 2020.CNTX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$32.55 M
-$12.52 M-62.52%
01 September 2024
Summary:
Context Therapeutics TTM operating income is currently -$32.55 million, with the most recent change of -$12.52 million (-62.52%) on 01 September 2024. Over the past year, it has dropped by -$10.52 million (-47.79%). CNTX TTM operating profit is now -6409.32% below its all-time high of -$500.00 thousand, reached on 31 March 2020.CNTX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNTX Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -68.5% | -202.6% | -47.8% |
| 3 y3 years | -874.8% | -1092.6% | -536.2% |
| 5 y5 years | - | - | - |
CNTX Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -874.8% | at low | -1092.6% | at low | -536.2% | at low |
| 5 y | 5 years | -874.8% | at low | -3640.3% | at low | -6409.3% | at low |
| alltime | all time | -874.8% | at low | -3640.3% | at low | -6409.3% | at low |
Context Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$18.70 M(+505.5%) | -$32.55 M(+62.5%) |
| June 2024 | - | -$3.09 M(-19.2%) | -$20.03 M(-9.9%) |
| Mar 2024 | - | -$3.82 M(-44.9%) | -$22.23 M(-11.3%) |
| Dec 2023 | -$25.07 M(+68.5%) | -$6.93 M(+12.2%) | -$25.07 M(+13.9%) |
| Sept 2023 | - | -$6.18 M(+16.8%) | -$22.02 M(+10.7%) |
| June 2023 | - | -$5.29 M(-20.6%) | -$19.89 M(+9.9%) |
| Mar 2023 | - | -$6.67 M(+71.7%) | -$18.10 M(+21.7%) |
| Dec 2022 | -$14.88 M | -$3.88 M(-4.1%) | -$14.88 M(+5.6%) |
| Sept 2022 | - | -$4.05 M(+15.4%) | -$14.09 M(+21.4%) |
| June 2022 | - | -$3.51 M(+1.9%) | -$11.61 M(+15.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$3.44 M(+11.4%) | -$10.04 M(+35.0%) |
| Dec 2021 | -$7.44 M(+189.2%) | -$3.09 M(+97.2%) | -$7.44 M(+45.4%) |
| Sept 2021 | - | -$1.57 M(-19.1%) | -$5.12 M(+21.8%) |
| June 2021 | - | -$1.94 M(+130.6%) | -$4.20 M(+44.2%) |
| Mar 2021 | - | -$840.30 K(+9.2%) | -$2.91 M(+13.2%) |
| Dec 2020 | -$2.57 M(-52.2%) | -$769.50 K(+18.2%) | -$2.57 M(+42.7%) |
| Sept 2020 | - | -$651.10 K(-0.1%) | -$1.80 M(+56.5%) |
| June 2020 | - | -$651.60 K(+30.3%) | -$1.15 M(+130.3%) |
| Mar 2020 | - | -$500.00 K | -$500.00 K |
| Dec 2019 | -$5.38 M | - | - |
FAQ
- What is Context Therapeutics annual operaing income?
- What is the all time high annual operating profit for Context Therapeutics?
- What is Context Therapeutics annual operating profit year-on-year change?
- What is Context Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Context Therapeutics?
- What is Context Therapeutics quarterly operating profit year-on-year change?
- What is Context Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Context Therapeutics?
- What is Context Therapeutics TTM operating profit year-on-year change?
What is Context Therapeutics annual operaing income?
The current annual operating profit of CNTX is -$25.07 M
What is the all time high annual operating profit for Context Therapeutics?
Context Therapeutics all-time high annual operaing income is -$2.57 M
What is Context Therapeutics annual operating profit year-on-year change?
Over the past year, CNTX annual operaing income has changed by -$10.19 M (-68.49%)
What is Context Therapeutics quarterly operating income?
The current quarterly operating profit of CNTX is -$18.70 M
What is the all time high quarterly operating profit for Context Therapeutics?
Context Therapeutics all-time high quarterly operating income is -$500.00 K
What is Context Therapeutics quarterly operating profit year-on-year change?
Over the past year, CNTX quarterly operating income has changed by -$12.52 M (-202.59%)
What is Context Therapeutics TTM operating income?
The current TTM operating profit of CNTX is -$32.55 M
What is the all time high TTM operating profit for Context Therapeutics?
Context Therapeutics all-time high TTM operating income is -$500.00 K
What is Context Therapeutics TTM operating profit year-on-year change?
Over the past year, CNTX TTM operating income has changed by -$10.52 M (-47.79%)